Business Segments · Net Sales
Diagnostic Products — Net Sales
Abbott Diagnostic Products — Net Sales decreased by 11.3% to $2.18B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.1%, from $2.05B to $2.18B. Over 4 years (FY 2021 to FY 2025), Diagnostic Products — Net Sales shows a downward trend with a -13.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market share or higher demand for diagnostic testing, while a decrease may signal market saturation or loss of competitive positioning.
Detailed definition
Represents the total revenue generated from the sale of diagnostic equipment, testing kits, and related services within...
Peer comparison
Standard revenue metric across all medical device and diagnostics peers.
Metric ID:
abt_segment_diagnostic_products_net_salesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 3.2B | 3.9B | 4.5B | 5.3B | 4.3B | 3.7B | 3.3B | 2.7B | 2.3B | 2.4B | 2.5B | 2.2B | 2.2B | 2.4B | 2.5B | 2.1B | 2.2B | 2.3B | 2.5B | 2.2B |
| QoQ Change | — | +20.5% | +14.3% | +18.2% | -18.2% | -15.1% | -10.0% | -18.7% | -13.8% | +5.7% | +3.5% | -12.6% | -0.9% | +9.9% | +4.5% | -18.5% | +5.8% | +3.7% | +9.1% | -11.3% |
| YoY Change | — | — | — | — | +33.1% | -6.2% | -26.1% | -49.1% | -46.4% | -33.3% | -23.3% | -17.6% | -5.3% | -1.5% | -0.6% | -7.2% | -1.0% | -6.6% | -2.5% | +6.1% |
Range2.1B – 5.3B
CAGR-8.0%
Avg YoY Growth-11.7%
Median YoY Growth-6.4%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Abbott's diagnostic products — net sales?
- Abbott (ABT) reported diagnostic products — net sales of $2.18B in Q1 2026.
- How has Abbott's diagnostic products — net sales changed year-over-year?
- Abbott's diagnostic products — net sales increased by 6.1% year-over-year, from $2.05B to $2.18B.
- What is the long-term trend for Abbott's diagnostic products — net sales?
- Over 4 years (2021 to 2025), Abbott's diagnostic products — net sales has grown at a -13.1% compound annual growth rate (CAGR), from $15.64B to $8.94B.
- What does diagnostic products — net sales mean?
- Total revenue earned from the diagnostics business segment.